My world got flipped upside down at 22
Colorectal cancer, long considered a disease of older adults, is quietly rewriting its own rules — appearing with increasing frequency in people in their twenties, thirties, and forties. Kirsten Scheller was 22 when a stage 3 diagnosis finally ended years of misdiagnosis, a delay that speaks to how powerfully assumptions about age and risk can shape — and sometimes distort — medical judgment. Now 36 and in remission, she has turned her experience into a public argument for listening to the body before the guidelines give permission to do so. Her story arrives at a moment when medicine itself is being asked to reckon with the gap between established screening thresholds and a shifting biological reality.
- Colorectal cancer cases are rising sharply among adults under 50, exposing a dangerous blind spot in screening guidelines built for an older generation.
- Kirsten Scheller spent years being told her symptoms were hemorrhoids — a misdiagnosis that held until a new doctor finally looked inside and found stage 3 cancer at age 22.
- The medical establishment's recommended screening age of 45 remains in place, but cases like Scheller's are forcing an uncomfortable question: who falls through the gap?
- Scheller now undergoes AI-assisted colonoscopies every 9 to 12 months, a surveillance regimen that keeps her in remission and illustrates how technology is beginning to sharpen what the human eye alone can miss.
- Honored as a Medtronic Game Changer at a Vikings game, Scheller has channeled her diagnosis into advocacy — urging anyone with persistent symptoms to push back against easy answers, regardless of age or family history.
Colorectal cancer has begun appearing in people who should, by conventional wisdom, be too young to worry about it. Cases among adults under 50 are climbing, catching the medical establishment somewhat flat-footed and prompting a reckoning with screening guidelines that have held steady for years.
Kirsten Scheller was 19 when her body started sending signals. The symptoms were persistent but not dramatic, and she was active, healthy, and without a family history that might have raised alarms. Doctors looked at her age and concluded she had internal hemorrhoids. That diagnosis held for years — until a new gastroenterologist suggested actually looking inside. What they found was stage 3 colon cancer. "My world got flipped upside down," she recalled. She underwent treatment and has been in remission since age 23.
Now 36 and recently honored at a Vikings game as a Medtronic Game Changer, Scheller has made advocacy her ongoing work. She is careful not to dismiss the current guideline recommending screening begin at 45 — it exists for sound epidemiological reasons — but she insists that anyone experiencing symptoms should push for evaluation rather than accept a dismissal based on age alone.
Her own surveillance now involves AI-enabled colonoscopies every 9 to 12 months, a regimen that keeps her cancer in check while illustrating how artificial intelligence is helping gastroenterologists catch what the human eye might miss. The deeper lesson of her story, though, is older than any technology: when something feels wrong, push back against easy answers. The disease, as she has learned, does not consult the screening guidelines before it arrives.
Colorectal cancer has begun appearing in people who should, by conventional wisdom, be too young to worry about it. Cases among adults under 50 are climbing, a shift that has caught the medical establishment somewhat flat-footed and prompted a reckoning with screening guidelines that have held steady for years.
Kirsten Scheller was 19 when her body started sending signals something was wrong. The symptoms were there, persistent enough to notice, but not so dramatic that anyone—including her—suspected cancer. She was active, healthy, without the family history that typically flags someone as high-risk. Doctors looked at her age and her profile and concluded she had internal hemorrhoids. That diagnosis stuck for years, even as the symptoms continued. It wasn't until she was 22 that a new gastroenterologist took a different approach, suggesting a flexible sigmoidoscopy to actually look inside and see what was happening. What they found was stage 3 colon cancer.
"My world got flipped upside down," Scheller said, reflecting on that moment when the misdiagnosis finally resolved into something far more serious. She underwent treatment and has been in remission since age 23. Now 36, she carries that experience with her—not as a closed chapter but as a reason to speak up. Recently honored at a Vikings game as a Medtronic Game Changer, she has become an advocate for early screening and, perhaps more importantly, for listening to your own body when something feels off.
The medical establishment currently recommends that colorectal cancer screening begin at age 45. That guideline exists for good reason, based on decades of epidemiological data. But Scheller's case, and the rising tide of similar cases in younger adults, suggests the picture is more complicated. She emphasizes that while 45 may be the standard starting point, anyone experiencing symptoms—regardless of age or family history—should push for evaluation rather than accept a dismissal.
Scheller's own path forward has involved ongoing surveillance. She undergoes AI-enabled colonoscopies every 9 to 12 months through Medtronic, a regimen that keeps her cancer in check and allows her to live her life with the knowledge that she is being watched over. The technology itself represents a shift in how screening can work: artificial intelligence now helps gastroenterologists spot polyps and early signs of disease that might otherwise be missed by the human eye alone.
What Scheller's story underscores is the power of self-advocacy in medicine. She was misdiagnosed because she didn't fit the profile. She got answers only when she—or rather, a new doctor—insisted on looking deeper. That same principle applies now as colorectal cancer increasingly shows up in people in their 20s, 30s, and 40s. The disease doesn't care about age recommendations. It cares about biology. And biology, it turns out, is more varied and unpredictable than the screening guidelines sometimes suggest. For anyone experiencing persistent digestive symptoms, the lesson is clear: push back against easy answers, advocate for yourself, and don't let your age or your health history convince you that something serious couldn't be happening.
Citas Notables
I don't have any major family history of any type of cancer, and I was really active and healthy, so they thought it was internal hemorrhoids.— Kirsten Scheller
At 22, getting diagnosed, my world got flipped upside down.— Kirsten Scheller
La Conversación del Hearth Otra perspectiva de la historia
Why does it matter that colorectal cancer is showing up in younger people? Isn't cancer always going to affect some percentage of the population?
It matters because the medical system is built around age. We tell people not to worry until 45. Kirsten was 19, so nobody looked. If the disease is actually shifting younger, then the system is missing cases—people like her, sitting in waiting rooms being told it's something harmless.
But she was eventually diagnosed. The system worked, just slowly.
It worked, but it cost her years of uncertainty and then a stage 3 diagnosis instead of something caught earlier. That's the difference between catching cancer when it's small and treatable versus when it's already spread. Those years of misdiagnosis weren't just inconvenient—they were dangerous.
What does self-advocacy actually mean in this context? What was she supposed to do differently?
She did what she could—she noticed something was wrong. But she was 19, probably trusting what doctors told her. The real shift came when she saw a doctor willing to actually look, to do the test instead of just accepting the easy diagnosis. Self-advocacy means pushing back, asking for more, not accepting "you're too young" as an answer when your body is telling you something else.
Is the solution to screen everyone under 50?
Not necessarily. But it's to listen when people have symptoms, regardless of age. And it's to recognize that the old categories—family history, age, health status—don't predict everything. Kirsten had none of the risk factors. She still got cancer. That's the humbling part.